Learn More
Genscript Corporation CD200/OX-2 His Cynomolgus
Supplier: Genscript Corporation Z04109500
CD200 and its receptors are highly expressed in the lung on epithelial cells and leukocytes and emerging evidence links dysregulation of the CD200 pathway with asthma Moreover pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.